Clinical Trial Update: PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB [Phase 2]

View source ↗

Summary

Phase 2 trial updating pharmacokinetics of rifampicin interactions with Depo-Provera (DMPA) and efavirenz in HIV and TB patients; completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• DMPA (medroxyprogesterone acetate)
• EFAVIRENZ (efavirenz)
• Rifampicin

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection, Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2018-09-25